Advita Ortho has appointed Christopher Lin as chief legal officer and Christine Thomas, RAC as chief quality, regulatory, and clinical officer.

Lin joined Advita in November 2025, with over two decades of experience as a corporate attorney, M&A professional, and operations executive. In his role, he oversees legal, compliance, corporate governance, risk management, and corporate development.

Before joining Advita, Lin was chief administrative officer and general counsel at Pristine Surgical. He also spent six years at Arthrex as deputy general counsel and director of corporate development.

Thomas boasts more over 25 years of executive leadership experience in regulatory affairs, quality systems, and clinical strategy in the medical device industry. She leads Advita’s global quality, regulatory, and clinical functions.

She’s had senior leadership roles for a wide range of medical technologies, including capital equipment, infusion pump systems, and women’s health innovations. Thomas’ experience includes securing FDA 510(k) clearances, PMA approvals, and EU MDR CE mark Class III approvals, as well as market authorizations globally.

Before joining Advita, Thomas was in leadership roles at Femasys, IQVIA, RTI Surgical, Cardiac Science (now ZOLL Medical), Smiths Medical (now ICU Medical), Vascular Solutions (now Teleflex), Boston Scientific, and GE Healthcare.

“These appointments reflect Advita’s continued investment in strong, experienced leadership as we continue to scale and advance our purpose, mission and goals,” said Aurelio Sahagun, Advita Ortho’s CEO. “Chris and Christine bring fresh perspective, deep expertise, and proven leadership that will help shape our growth and solidify our standing in the orthopedic industry.”

Find out more about Advita Ortho in this feature article!